37,383 Shares in Arvinas Inc (ARVN) Purchased by Dean Capital Investments Management LLC

Dean Capital Investments Management LLC bought a new stake in shares of Arvinas Inc (NASDAQ:ARVN) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 37,383 shares of the company’s stock, valued at approximately $631,000. Dean Capital Investments Management LLC owned approximately 0.12% of Arvinas as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in ARVN. FMR LLC bought a new position in shares of Arvinas during the third quarter valued at approximately $10,308,000. BlackRock Inc. bought a new stake in shares of Arvinas during the third quarter valued at approximately $4,399,000. Yale University bought a new stake in shares of Arvinas during the third quarter valued at approximately $3,114,000. JPMorgan Chase & Co. bought a new stake in shares of Arvinas during the third quarter valued at approximately $2,234,000. Finally, Birchview Capital LP bought a new stake in shares of Arvinas during the third quarter valued at approximately $506,000. 12.65% of the stock is owned by institutional investors and hedge funds.

Several brokerages recently weighed in on ARVN. Citigroup began coverage on shares of Arvinas in a research report on Monday, October 22nd. They set a “buy” rating and a $21.00 price target for the company. Piper Jaffray Companies began coverage on shares of Arvinas in a research report on Monday, October 22nd. They set an “overweight” rating and a $23.00 price target for the company. Finally, Goldman Sachs Group began coverage on shares of Arvinas in a research report on Monday, October 22nd. They set a “neutral” rating and a $17.00 price target for the company.

Shares of ARVN opened at $16.96 on Friday. Arvinas Inc has a twelve month low of $13.70 and a twelve month high of $21.25.

In related news, Director Bradley Albert Margus acquired 40,000 shares of the stock in a transaction on Monday, October 1st. The stock was bought at an average cost of $16.00 per share, with a total value of $640,000.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider James E. Flynn acquired 312,500 shares of the stock in a transaction on Monday, October 1st. The stock was bought at an average cost of $16.00 per share, with a total value of $5,000,000.00. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 354,100 shares of company stock valued at $5,665,600.

ILLEGAL ACTIVITY WARNING: This report was published by WKRB News and is the sole property of of WKRB News. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.wkrb13.com/2018/11/23/37383-shares-in-arvinas-inc-arvn-purchased-by-dean-capital-investments-management-llc.html.

About Arvinas

Arvinas Holding Company, LLC, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, proteolysis targeting chimeras (PROTAC) targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC targeting the estrogen receptor protein for the treatment of women with metastatic ER+ breast cancer.

Read More: The Role of a Fiduciary and Individual Investors

Want to see what other hedge funds are holding ARVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arvinas Inc (NASDAQ:ARVN).

Institutional Ownership by Quarter for Arvinas (NASDAQ:ARVN)

Receive News & Ratings for Arvinas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arvinas and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply